CM Life Sciences III (CMLT) Shareholders Approve EQRx Deal
by Marlena Haddad on 2021-12-17 at 6:23am

CM Life Sciences III (NASDAQ:CMLT) announced this morning that its shareholders approved its combination with biotech firm EQRx in a special meeting yesterday.

The 8-K did not disclose redemption figures but, CM III went into the vote with at least some risk having traded below $10 since August. Following close, the combined company is expected to trade on the Nasdaq under the symbol “EQRX”

CM Life Sciences III initially announced the $3.54 billion combination with EQRx on August 6. Cambridge, Massachusetts-based EQRx is developing a range of drug candidates both generated in-house and licensed from peers with an aim to reducing the overall cost of pharmaceutical rollouts.

All measures on the company’s ballot passed by large margins, but some received dissenting votes amounting to about 19% of participating shares. For full vote tallies, click here.


ADVISORS

  • J.P. Morgan Securities, LLC is acting as the lead financial advisor, with Goldman Sachs & Co. LLC also acting as a financial advisor.
  • PJT Partners LP is also acting as a financial advisor and Goodwin Procter LLP is serving as the legal advisor to EQRx.
  • Jefferies LLC and Cowen and Company, LLC are acting as joint capital markets advisors.
  • White & Case LLP is serving as legal advisor to CM Life Sciences III.
  • Jefferies LLC, Cowen and Company, LLC and J.P. Morgan Securities LLC are acting as joint placement agents.
Recent Posts
by Nicholas Alan Clayton on 2024-11-15 at 11:28am

Few corners of the market have seen a bigger boost from the result of the US elections than the crypto industry, and SPACs are always sure to be drawn to where the action is. But, in crypto’s case, this is a play that SPACs have been involved in before, so the question is more of...

by Nicholas Alan Clayton on 2024-11-15 at 8:26am

At the SPAC of Dawn As more information continues to trickle out about what investors should expect from the Trump 2.0 tax changes, it has become increasingly clear that the $7,500 EV tax credit is on the outs. Such a change could shift the strategies for many EV de-SPACs and prospective SPAC targets in the...

by Nicholas Alan Clayton on 2024-11-14 at 8:04pm

Horizon Space Acquisition II Corp. (NASDAQ:HSPTU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “HSPTU”, Friday, November 15, 2024. The new SPAC intends to make a broad search for a target with a strong management team and long-term revenue visibility. Horizon...

by Nicholas Alan Clayton on 2024-11-14 at 8:15am

At the SPAC of Dawn The US is set to get its first jobs report of the post-election period as well as the producer price index (PPI) for several baskets of products. Traders will be waiting to see if the PPI reflects the same unexpected bump in inflation recorded in the last consumer price index...

by Nicholas Alan Clayton on 2024-11-13 at 8:26am

At the SPAC of Dawn As the SPAC market has come streaming back to life in a burst of new issuance beginning this summer, some long abandoned vehicles are rising anew as well. The latest of these is FPA Energy (NASDAQ:FPAQU), whose 2023 filing was later withdrawn, but it is now back with a fresh...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved